Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03532880 · ClinicalTrials.gov registry record · Phase 1
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT03532880: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03532880 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03532880, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety of a new medication, Olaparib, combined with radiation therapy for participants with small cell lung cancer.
Interventions
- DRUG Olaparib Pill 50 mg
- DRUG Olaparib Pill 100 mg
- DRUG Olaparib Pill 150 mg
- DRUG Olaparib Pill 200 mg
- DRUG Olaparib Pill 250 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2025-02-04 |
| Phase | Phase 1 |
What the finished NCT03532880 record still lists
NCT03532880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 5 interventions - of which Olaparib Pill 50 mg is the first listed.
NCT03532880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03532880 about?
NCT03532880 is a clinical study titled "A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer". The purpose of this study is to test the safety of a new medication, Olaparib, combined with radiation therapy for participants with small cell lung cancer.
What is the current status of trial NCT03532880?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2018-07-12. Estimated completion is 2025-02-04.
What interventions are being tested in trial NCT03532880?
The interventions under investigation include: Olaparib Pill 50 mg (DRUG), Olaparib Pill 100 mg (DRUG), Olaparib Pill 150 mg (DRUG), Olaparib Pill 200 mg (DRUG), Olaparib Pill 250 mg (DRUG).
Who is sponsoring clinical trial NCT03532880?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03532880's enrollment target sits among peer trials
26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI